Introduction: Medium cutoff (MCO) membranes represent an interesting innovation in the field of hemodialysis. Given the correlation between large (PM >25 kDa) middle molecules (LMM) and clinical outcomes, the possibility to broaden the spectrum of solutes removed in hemodialysis with MCO membranes introduces a new perspective for end-stage kidney disease patients. Due to low diffusion coefficients of LMM, the use of convection is required to maximize extracorporeal clearance. High convective rates are achieved with high-flux membranes in hemodiafiltration, a technique not available in the US. In case of the MCO membrane, remarkable clearances of LMM are achieved combining the permeability of the membrane with a significant amount of internal convection. The mechanism of filtration-backfiltration inside the dialyzer enables effective removal of LMM in a technique called expanded hemodialysis (HDx). Given such theoretical explanation, it is important to demonstrate the blood and ultrafiltration rheology inside the MCO dialyzer. Method: This study for the first time describes flow dynamic parameters and internal cross-filtration, thanks to specific radiology and nuclear imaging techniques. Results: Flow dynamic analysis of the blood and dialysate compartment confirms excellent distribution of velocities and an excellent matching of blood and dialysate. Average blood flow velocity allows for wall shear rates adequate to avoid protein stagnation at the blood membrane interface and increase in blood viscosity. Cross-filtration analysis demonstrates a remarkable filtration/backfiltration flux reaching values >30 mL/min at a blood flow of 300 mL/min and zero net filtration. Conclusion: The MCO dialyzer Theranova 400 appears to have a design optimized to perform expanded hemodialysis (HDx).

1.
Boschetti-de-Fierro
A
,
Voigt
M
,
Storr
M
,
Krause
B
.
Extended characterization of a new class of membranes for blood purification: the high cut-off membranes
.
Int J Artif Organs
.
2013
;
36
:
455
63
. .
2.
Ronco
C
,
Clark
WR
.
Haemodialysis membranes
.
Nat Rev Nephrol
.
2018
;
14
(
6
):
394
410
. .
3.
Rosner
MH
,
Reis
T
,
Husain-Syed
F
,
Vanholder
R
,
Hutchison
C
,
Stenvinkel
P
,
A new definition and classification of middle molecules and their role in uremia: an expert consensus conference
.
CJASN. Forthcoming
.
2021
.
4.
Wolley
M
,
Jardine
M
,
Hutchison
CA
.
Exploring the clinical relevance of providing increased removal of large middle molecules
.
Clin J Am Soc Nephrol
.
2018
;
13
:
805
14
. .
5.
Cozzolino
M
,
Ronco
C
.
Medium cut-off membranes: incremental or quantum leap innovation in haemodialysis?
Blood Purif
.
2020
;
1
4
.
6.
Ronco
C
,
Brendolan
A
,
Feriani
M
,
Milan
M
,
Conz
P
,
Lupi
A
,
A new scintigraphic method to characterize ultrafiltration in hollow fiber dialyzers
.
Kidney Int
.
1992 May
;
41
(
5
):
1383
93
. .
7.
Fiore
GB
,
Guadagni
G
,
Lupi
A
,
Ricci
Z
,
Ronco
C
.
A new semiempirical mathematical model for prediction of internal filtration in hollow fiber hemodialyzers
.
Blood Purif
.
2006
;
24
(
5–6
):
555
68
. .
8.
Lorenzin
A
,
Neri
M
,
Lupi
A
,
Todesco
M
,
Santimaria
M
,
Alghisi
A
,
Quantification of internal filtration in hollow fiber hemodialyzers with medium cut-off membrane
.
Blood Purif
.
2018
;
46
(
3
):
196
204
. .
9.
Ronco
C
,
Levin
N
,
Brendolan
A
,
Nalesso
F
,
Cruz
D
,
Ocampo
C
,
Flow distribution analysis by helical scanning in polysulfone hemodialyzers: effects of fiber structure and design on flow patterns and solute clearances
.
Hemodial Int
.
2006 Oct
;
10
(
4
):
380
8
. .
10.
Ronco
C
,
Brendolan
A
,
Lupi
A
,
Metry
G
,
Levin
NW
.
Effects of a reduced inner diameter of hollow fibers in hemodialyzers
.
Kidney Int
.
2000
;
58
:
809
17
. .
11.
Weiner
DE
,
Falzon
L
,
Skoufos
L
,
Bernardo
A
,
Beck
W
,
Xiao
M
,
Efficacy and safety of expanded hemodialysis with the theranova 400 dialyzer: a randomized controlled trial
.
Clin J Am Soc Nephrol
.
2020
;
15
(
9
):
1310
9
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.